These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18574404)

  • 1. Receptor pair for schizophrenia.
    Sealfon SC; González-Maeso J
    Pediatr Res; 2008 Jul; 64(1):1. PubMed ID: 18574404
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.
    Moreno JL; Kurita M; Holloway T; López J; Cadagan R; Martínez-Sobrido L; García-Sastre A; González-Maeso J
    J Neurosci; 2011 Feb; 31(5):1863-72. PubMed ID: 21289196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a serotonin/glutamate receptor complex implicated in psychosis.
    González-Maeso J; Ang RL; Yuen T; Chan P; Weisstaub NV; López-Giménez JF; Zhou M; Okawa Y; Callado LF; Milligan G; Gingrich JA; Filizola M; Meana JJ; Sealfon SC
    Nature; 2008 Mar; 452(7183):93-7. PubMed ID: 18297054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics and schizophrenia.
    González-Maeso J; Sealfon SC
    Trends Neurosci; 2009 Apr; 32(4):225-32. PubMed ID: 19269047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and novel approaches to the drug treatment of schizophrenia.
    Rowley M; Bristow LJ; Hutson PH
    J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639
    [No Abstract]   [Full Text] [Related]  

  • 6. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The two faces of the pharmacological interaction of mGlu2 and 5-HT₂A - relevance of receptor heterocomplexes and interaction through functional brain pathways.
    Delille HK; Mezler M; Marek GJ
    Neuropharmacology; 2013 Jul; 70():296-305. PubMed ID: 23466331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating novel targets for pharmacological interventions in schizophrenia.
    Wroblewska B; Lewis DA
    Am J Psychiatry; 2009 Jul; 166(7):753-6. PubMed ID: 19570936
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroscience: a complex in psychosis.
    Snyder SH
    Nature; 2008 Mar; 452(7183):38-9. PubMed ID: 18322519
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical models of antipsychotic drug action.
    Moreno JL; González-Maeso J
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2131-44. PubMed ID: 23745738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia.
    Stansley BJ; Conn PJ
    Curr Opin Pharmacol; 2018 Feb; 38():31-36. PubMed ID: 29486374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interaction of mGlu2 and 5-HT
    Ibi D
    Pharmacol Biochem Behav; 2022 Nov; 221():173474. PubMed ID: 36244526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET (positron emission tomography) research on schizophrenia].
    Takano A; Suhara T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):177-83. PubMed ID: 16971782
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of prefrontal cortical 5-HT
    Mitazaki S; Nakagawasai O; Onogi H; Watanabe K; Takahashi K; Tan-No K; Quirion R; Srivastava LK; Tadano T
    Behav Brain Res; 2020 Jan; 377():112226. PubMed ID: 31521737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.
    Moreno JL; Miranda-Azpiazu P; García-Bea A; Younkin J; Cui M; Kozlenkov A; Ben-Ezra A; Voloudakis G; Fakira AK; Baki L; Ge Y; Georgakopoulos A; Morón JA; Milligan G; López-Giménez JF; Robakis NK; Logothetis DE; Meana JJ; González-Maeso J
    Sci Signal; 2016 Jan; 9(410):ra5. PubMed ID: 26758213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 5-HT2A receptors in antipsychotic activity.
    Schmidt CJ; Sorensen SM; Kehne JH; Carr AA; Palfreyman MG
    Life Sci; 1995; 56(25):2209-22. PubMed ID: 7791509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Serotonin 5-HT
    Kantrowitz JT
    CNS Drugs; 2020 Sep; 34(9):947-959. PubMed ID: 32783116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.
    Maj C; Minelli A; Giacopuzzi E; Sacchetti E; Gennarelli M
    Curr Neuropharmacol; 2016; 14(5):540-50. PubMed ID: 27296644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
    Wood MD; Scott C; Clarke K; Cato KJ; Patel N; Heath J; Worby A; Gordon L; Campbell L; Riley G; Davies CH; Gribble A; Jones DN
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):445-52. PubMed ID: 16918396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.